Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 02012D0715-20190604

Consolidated text: Commission Implementing Decision of 22 November 2012 establishing a list of third countries with a regulatory framework applicable to active substances for medicinal products for human use and the respective control and enforcement activities ensuring a level of protection of public health equivalent to that in the Union, in accordance with Directive 2001/83/EC of the European Parliament and of the Council (Text with EEA relevance) (2012/715/EU)Text with EEA relevance

ELI: http://data.europa.eu/eli/dec_impl/2012/715/2019-06-04

02012D0715 — EN — 04.06.2019 — 004.001


This text is meant purely as a documentation tool and has no legal effect. The Union's institutions do not assume any liability for its contents. The authentic versions of the relevant acts, including their preambles, are those published in the Official Journal of the European Union and available in EUR-Lex. Those official texts are directly accessible through the links embedded in this document

►B

COMMISSION IMPLEMENTING DECISION

of 22 November 2012

establishing a list of third countries with a regulatory framework applicable to active substances for medicinal products for human use and the respective control and enforcement activities ensuring a level of protection of public health equivalent to that in the Union, in accordance with Directive 2001/83/EC of the European Parliament and of the Council

(Text with EEA relevance)

(2012/715/EU)

(OJ L 325 23.11.2012, p. 15)

Amended by:

 

 

Official Journal

  No

page

date

 M1

COMMISSION IMPLEMENTING DECISION 2013/196/EU of 24 April 2013

  L 113

22

25.4.2013

 M2

COMMISSION IMPLEMENTING DECISION 2013/262/EU of 4 June 2013

  L 152

52

5.6.2013

 M3

COMMISSION IMPLEMENTING DECISION 2013/301/EU of 11 June 2013

  L 169

71

21.6.2013

 M4

COMMISSION IMPLEMENTING DECISION (EU) 2015/1057 Text with EEA relevance of 1 July 2015

  L 171

23

2.7.2015

►M5

COMMISSION IMPLEMENTING DECISION (EU) 2019/769 Text with EEA relevance of 14 May 2019

  L 126

70

15.5.2019




▼B

COMMISSION IMPLEMENTING DECISION

of 22 November 2012

establishing a list of third countries with a regulatory framework applicable to active substances for medicinal products for human use and the respective control and enforcement activities ensuring a level of protection of public health equivalent to that in the Union, in accordance with Directive 2001/83/EC of the European Parliament and of the Council

(Text with EEA relevance)

(2012/715/EU)



Article 1

The list of third countries referred to in Article 111b(1) of Directive 2001/83/EC is set out in the Annex to this Decision.

Article 2

This Decision shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

▼M5




ANNEX

List of third countries with a regulatory framework applicable to active substances for medicinal products for human use and the respective control and enforcement activities ensuring a level of protection of public health equivalent to that in the Union



Third country

Remarks

Australia

 

Brazil

 

Israel (1)

 

Japan

 

Republic of Korea

 

Switzerland

 

United States of America

 

(1)   Hereafter understood as the State of Israel, excluding the territories under Israeli administration since June 1967, namely the Golan Heights, the Gaza Strip, East Jerusalem and the rest of the West Bank.

Top